Type of Policy
|
|
|
Guideline |
13 (59%) |
15 (48%) |
Rule/Regulation |
4 (18%) |
4 (13%) |
Prior Authorization |
4 (18%) |
4 (13%) |
Legislative Act |
3 (14%) |
4 (13%) |
Claim Denial |
2 (9%) |
2 (6%) |
Alert System/Automatic Patient Report |
2 (9%) |
2 (6%) |
Sponsoring Organization
|
|
|
Medical Board |
9 (41%) |
9 (29%) |
Medicaid |
6 (27%) |
7 (23%) |
Workers’ Compensation |
5 (23%) |
6 (19%) |
Health Department |
5 (23%) |
5 (16%) |
State Legislature |
3 (14%) |
4 (13%) |
Pharmacy Board |
2 (9%) |
2 (6%) |
Prescription Drug Monitoring Program |
2 (9%) |
2 (6%) |
Threshold Level
|
|
|
30 |
2 (9%) |
2 (6%) |
50 |
1 (5%) |
1 (3%) |
60 |
1 (5%) |
1 (3%) |
80 |
3 (14%) |
4 (13%) |
90 |
4 (18%) |
4 (13%) |
100 |
5 (23%) |
5 (16%) |
120 |
10 (45%) |
11 (35%) |
300 |
2 (9%) |
2 (6%) |
Patient exclusions
|
|
|
Terminal/hospice/palliative care patients |
12 (55%) |
14 (45%) |
Acute/etiologic pain |
10 (45%) |
10 (32%) |
Cancer/malignant pain |
8 (36%) |
11 (35%) |
Long-term care facility/nursing home patients |
5 (23%) |
5 (16%) |
Emergency Room care patients |
2 (9%) |
2 (6%) |
Other patient groups |
3 (14%) |
3 (10%) |
No patient groups excluded |
7 (32%) |
7 (23%) |
Short courses of opioids excluded
|
5 (23%) |
5 (16%) |
Excluded circumstances
|
|
|
Specialist consulted |
14 (64%) |
15 (48%) |
Pain contract/patient education |
7 (32%) |
7 (23%) |
Evidence of tapering |
4 (18%) |
4 (13%) |
Clinical judgment |
6 (27%) |
7 (23%) |
Improved pain or function |
5 (23%) |
5 (16%) |
Prescription Drug Monitoring Program checked |
4 (18%) |
4 (18%) |
Drug testing |
3 (14%) |
3 (10%) |
Other circumstances specified |
3 (14%) |
3 (10%) |
No circumstances specified |
9 (41%) |
10 (32%) |